Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Scott

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Epidemiology and Infection|March 4, 2022
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 - CORRIGENDUMAnna Lee Wilkinson, Alisa Pedrana, Michael W Traeger, et al.
Epidemiology and Infection|March 7, 2022
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019Anna Lee Wilkinson, Alisa Pedrana, Michael W Traeger, et al.
The Medical Journal of Australia|November 18, 2020
Modelling the impact of relaxing COVID-19 control measures during a period of low viral transmissionNick Scott, Anna Palmer, Dominic Delport, et al.
The Lancet Regional Health. Western Pacific|January 13, 2022
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling studyDr Nick Scott, Ms Anna Palmer, Mr Tom Tidhar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2019
Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject DrugsAmanda J Wade, Joseph S Doyle, Edward Gane, et al.
BMJ Open|February 11, 2025
Supervised Injecting Room Cohort Study (SIRX): study protocolAshleigh C Stewart, Matthew Hickman, Paul A Agius, et al.
Hepatology (Baltimore, Md.)|May 1, 2023
Pathway to global elimination of hepatitis B: HBV cure is just the first stepJessica Howell, Chris Seaman, Jack Wallace, et al.
The International Journal on Drug Policy|March 29, 2022
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020Anna Lee Wilkinson, Daniela K van Santen, Michael W Traeger, et al.
Health Research Policy and Systems|October 8, 2022
A framework for considering the utility of models when facing tough decisions in public health: a guideline for policy-makersJason Thompson, Roderick McClure, Nick Scott, et al.
The Lancet. Global Health|December 25, 2025
Diagnostic criteria for postpartum haemorrhage treatment: a cost-effectiveness studyNick Scott, Ioannis Gallos, Thomas Walsh, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Epidemiology and Infection|March 4, 2022
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 - CORRIGENDUMAnna Lee Wilkinson, Alisa Pedrana, Michael W Traeger, et al.
Epidemiology and Infection|March 7, 2022
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019Anna Lee Wilkinson, Alisa Pedrana, Michael W Traeger, et al.
The Medical Journal of Australia|November 18, 2020
Modelling the impact of relaxing COVID-19 control measures during a period of low viral transmissionNick Scott, Anna Palmer, Dominic Delport, et al.
The Lancet Regional Health. Western Pacific|January 13, 2022
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling studyDr Nick Scott, Ms Anna Palmer, Mr Tom Tidhar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2019
Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject DrugsAmanda J Wade, Joseph S Doyle, Edward Gane, et al.
BMJ Open|February 11, 2025
Supervised Injecting Room Cohort Study (SIRX): study protocolAshleigh C Stewart, Matthew Hickman, Paul A Agius, et al.
Hepatology (Baltimore, Md.)|May 1, 2023
Pathway to global elimination of hepatitis B: HBV cure is just the first stepJessica Howell, Chris Seaman, Jack Wallace, et al.
The International Journal on Drug Policy|March 29, 2022
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020Anna Lee Wilkinson, Daniela K van Santen, Michael W Traeger, et al.
Health Research Policy and Systems|October 8, 2022
A framework for considering the utility of models when facing tough decisions in public health: a guideline for policy-makersJason Thompson, Roderick McClure, Nick Scott, et al.
The Lancet. Global Health|December 25, 2025
Diagnostic criteria for postpartum haemorrhage treatment: a cost-effectiveness studyNick Scott, Ioannis Gallos, Thomas Walsh, et al.
Pageof 16